Transient osteoporosis of the hip in pregnancy. Successful treatment with calcitonin

被引:0
作者
Laktasic-Zeriavic, N.
Curkovic, B.
Babic-Naglic, D.
Potocki, K.
Prutki, M.
Soldo-Juresa, D.
机构
[1] Univ Zagreb, Ctr Hosp, Univ Dept Rheumatol, Zagreb 10000, Croatia
[2] Univ Zagreb, Hosp Ctr, Clin Inst Diagnost & Intervent Radiol, Zagreb 41000, Croatia
[3] Univ Zagreb, Dubrava Univ Hosp, Dept Med, Dept Immunol, Zagreb, Croatia
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2007年 / 66卷 / 06期
关键词
calcitonin; hip; magnetic resonance imaging; osteoporosis; pregnancy;
D O I
10.1007/s00393-007-0191-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transient osteoporosis of the hip is a rare clinical disorder of unknown etiology, characterized by hip pain and functional disability that resolves spontaneously in 6-24 months. Despite a benign prognosis, the long clinical course causes prolonged disability. We report on a case of transient osteoporosis of the hip during pregnancy that was rapidly resolved with the use of calcitonin. An accurate diagnosis was made 2 months after the onset of symptoms (4 weeks postpartum) based on findings in the form of bone marrow edema of the right hip by magnetic resonance imaging. The patient received calcitonin for 8 weeks and the beneficial effect was observed after 3 weeks of therapy with full resolution of symptoms after 8 weeks of therapy (4 months after onset of symptoms). We suggest that the use of calcitonin may be considered as a therapeutic intervention to shorten the disease duration.
引用
收藏
页码:510 / 513
页数:6
相关论文
共 50 条
[41]   Transient Osteoporosis of the Hip: Risk and Therapy [J].
Bashaireh, Khaldoon M. ;
Aldarwish, Fa'ek M. ;
Al-Omari, Ali A. ;
Albashaireh, Moath A. ;
Hajjat, Mai ;
Al-Ebbini, Mohammad A. ;
Aleshawi, Abdelwahab J. .
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2020, 12 :1-8
[42]   Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis [J].
Wu, F ;
Reid, IR .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) :S53-S56
[43]   Transient Osteoporosis of the Hip: A Case Report [J].
Ekinci, Deniz ;
Barut, A. Yuksel ;
Karagoz, Yesim ;
Orhan, Ozge .
ISTANBUL MEDICAL JOURNAL, 2008, 9 (04) :205-208
[44]   Transient osteoporosis of the hip: A densitometric study [J].
Varenna, M ;
Sinigaglia, L ;
Binelli, L ;
Beltrametti, P ;
Gallazzi, M .
CLINICAL RHEUMATOLOGY, 1996, 15 (02) :169-173
[45]   USE OF CALCITONIN IN THE TREATMENT OF BONE PAIN ASSOCIATED WITH OSTEOPOROSIS [J].
GENNARI, C ;
AGNUSDEI, D ;
CAMPOREALE, A .
CALCIFIED TISSUE INTERNATIONAL, 1991, 49 :S9-S13
[46]   Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis [J].
Bandeira, Leonardo ;
Lewiecki, E. Michael ;
Bilezikian, John P. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (06) :681-689
[47]   THE EFFECT OF TREATMENT WITH CALCITONIN ON VERTEBRAL FRACTURE RATE IN OSTEOPOROSIS [J].
BURCKHARDT, P ;
BURNAND, B .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (01) :24-30
[48]   POSTMENOPAUSAL OSTEOPOROSIS - PREVENTION AND TREATMENT WITH CALCITONIN [J].
PRELEVIC, GM ;
ADASHI, EY .
GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (02) :141-147
[49]   Transient osteoporosis of the hip: Presentation of (a)typical cases and a review of the literature [J].
Bijl, M ;
van Leeuwen, MA ;
van Rijswijk, MH .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (05) :601-604
[50]   Transient osteoporosis of the hip and spontaneous osteonecrosis of the knee: a common aetiology? [J].
M. E. A. P. M. Adriaensen ;
K. J. Mulhall ;
R. A. P. Borghans ;
P. Magill ;
E. C. Kavanagh .
Irish Journal of Medical Science, 2012, 181 :341-343